ImmuCell Corp. (ICCC)
9.75
+0.15
(+1.56%)
USD |
NASDAQ |
Oct 02, 16:00
ImmuCell 1 Year Total Returns (Daily) : 48.86% for Oct. 2, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 02, 2026 | 48.86% |
| October 01, 2026 | 45.45% |
| September 30, 2026 | 56.80% |
| September 29, 2026 | 60.84% |
| September 28, 2026 | 63.85% |
| September 25, 2026 | 64.19% |
| September 24, 2026 | 64.52% |
| September 23, 2026 | 61.13% |
| September 22, 2026 | 59.84% |
| September 21, 2026 | 69.97% |
| September 18, 2026 | 75.80% |
| September 17, 2026 | 76.64% |
| September 16, 2026 | 62.88% |
| September 15, 2026 | 61.01% |
| September 14, 2026 | 64.02% |
| September 11, 2026 | 60.69% |
| September 10, 2026 | 60.96% |
| September 09, 2026 | 60.88% |
| September 08, 2026 | 50.11% |
| September 04, 2026 | 51.84% |
| September 03, 2026 | 53.23% |
| September 02, 2026 | 61.81% |
| September 01, 2026 | 55.00% |
| August 31, 2026 | 52.97% |
| August 28, 2026 | 62.42% |
| Date | Value |
|---|---|
| August 27, 2026 | 64.26% |
| August 26, 2026 | 60.32% |
| August 25, 2026 | 61.71% |
| August 24, 2026 | 61.50% |
| August 21, 2026 | 68.23% |
| August 20, 2026 | 66.98% |
| August 19, 2026 | 71.69% |
| August 18, 2026 | 59.74% |
| August 17, 2026 | 58.94% |
| August 14, 2026 | 49.55% |
| August 13, 2026 | 66.92% |
| August 12, 2026 | 65.11% |
| August 11, 2026 | 64.41% |
| August 10, 2026 | 64.71% |
| August 07, 2026 | 79.15% |
| August 06, 2026 | 78.32% |
| August 05, 2026 | 73.81% |
| August 04, 2026 | 77.26% |
| August 03, 2026 | 84.00% |
| July 31, 2026 | 75.98% |
| July 30, 2026 | 71.21% |
| July 29, 2026 | 69.65% |
| July 28, 2026 | 69.53% |
| July 27, 2026 | 68.38% |
| July 24, 2026 | 63.17% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -6.69% |
| Alnylam Pharmaceuticals, Inc. | -52.34% |
| Savara, Inc. | 37.82% |
| Vericel Corp. | 27.38% |
| Biogen, Inc. | 41.63% |